The Nexvax2 vaccine, which was developed by researchers at the Walter and Eliza Hall Institute and Royal Melbourne Hospital, aims to reprogram an abnormal immune system response to gluten.
World first vaccine for Australians living with coeliac disease could end need for gluten-free diets
